Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | MLNR | O43193 | 1/20 | 0.68 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.68 |
| ▸ | PGR | P06401 | 1/20 | 0.68 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.68 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.68 |
| ▸ | DRD2 | P14416 | 1/20 | 0.68 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.68 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.68 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.68 |
| ▸ | CNR1 | P21554 | 1/20 | 0.68 |
| ▸ | DRD1 | P21728 | 1/20 | 0.68 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.68 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.68 |
| ▸ | HRH2 | P25021 | 1/20 | 0.68 |
| ▸ | HTR2C | P28335 | 1/20 | 0.68 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.68 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.68 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13657407 | 0.96 | BLM (0.75) | BLMMLNRNR1I2PGRADRB1 | |
| SCHEMBL14597388 | 0.96 | BLM (0.75) | BLMMLNRNR1I2PGRADRB1 | |
| Bromide SCHEMBL31621175 | 0.95 | BLM (0.74) | BLMMLNRNR1I2PGRADRB1 | |
| SCHEMBL17445527 | 0.95 | BLM (0.76) | BLMMLNRNR1I2PGRADRB1 | |
| SCHEMBL16692020 | 0.93 | PRMT1 (0.72) | BLMMLNRNR1I2PGRADRB1 | |
| SCHEMBL19130572 | 0.93 | PRMT1 (0.72) | BLMMLNRNR1I2PGRADRB1 | |
| SCHEMBL19632961 | 0.92 | BLM (0.72) | BLMMLNRNR1I2PGRADRB1 | |
| SCHEMBL24968104 | 0.91 | PRMT1 (0.69) | BLMMLNRNR1I2PGRADRB1 | |
| SCHEMBL18308470 | 0.91 | BLM (0.67) | BLMMLNRNR1I2PGRADRB1 | |
| SCHEMBL249681 | 0.91 | MLNR (0.83) | BLMMLNRNR1I2PGRADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230211000-A1 | TISSUE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF | Blaze Bioscience, Inc. | 2023-07-06 | — | — | US | disclosed |
| US-11559580-B1 | Tissue-homing peptide conjugates and methods of use thereof | Blaze Bioscience, Inc. (US) | 2023-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230211000-A1 | TISSUE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF | CXCL12, CCL2, CD44 | BLM 4017/4885MLNR 439/4885NR1I2 4383/4885 |
| US-11559580-B1 | Tissue-homing peptide conjugates and methods of use thereof | CXCL12, CCL2, CD44 | BLM 4017/4885MLNR 439/4885NR1I2 4383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.